Mesoblast MEOBF
NASDAQ MEOBF
$1.90 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Mesoblast (MEOBF) Consolidated Net Income (2014 - 2023)

Mesoblast's (MEOBF) quarterly Consolidated Net Income came in at -$21.6 million in Q2 2023, down 113.31% year-over-year from $162.1 million in Q2 2022, and down 15.42% quarter-over-quarter from -$18.7 million in Q1 2023.

Analysis

Mesoblast (MEOBF) Consolidated Net Income (2014 - 2023) Analysis & Trends

Mesoblast has disclosed Consolidated Net Income across 10 years of filings, most recently posting -$21.6 million for Q2 2023.

  • In Q2 2023, Consolidated Net Income fell 113.31% year-over-year to -$21.6 million; the TTM figure through Jun 2023 stood at -$81.9 million (down 189.18% YoY), while the FY2026 annual figure was $56.3 million, down 44.55% from the prior year.
  • Consolidated Net Income came in at -$21.6 million for Q2 2023 at Mesoblast, down from -$18.7 million in the prior quarter.
  • In the past five years, Consolidated Net Income ranged from a high of $178.7 million in Q2 2021 to a low of -$57.6 million in Q1 2020.
  • Average Consolidated Net Income over 5 years is -$3.0 million, with a median of -$24.6 million recorded in 2022.
  • Year-over-year, Consolidated Net Income soared 55.32% in 2019 and tumbled 178.18% in 2020.
  • Over 5 years, Consolidated Net Income stood at -$38.5 million in 2019, then jumped by 33.6% to -$25.5 million in 2020, then declined by 2.2% to -$26.1 million in 2021, then advanced by 5.66% to -$24.6 million in 2022, then increased by 12.4% to -$21.6 million in 2023.
  • Per Business Quant data, the three most recent Consolidated Net Income figures were -$21.6 million in Q2 2023, -$18.7 million in Q1 2023, and -$24.6 million in Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Krystal Biotech 10.27 Bn 9.42 Bn 112.79 Mn 54.77 Mn
2 CRISPR Therapeutics AG 5.20 Bn 5.20 Bn - -91.19 Mn
3 Iovance Biotherapeutics 3.78 Bn 3.49 Bn 55.72 Mn -47.29 Mn
4 Legend Biotech 3.68 Bn 2.71 Bn 251.50 Mn 77.80 Mn
5 uniQure 3.06 Bn 3.06 Bn 5.49 Mn -81.06 Mn
6 Beam Therapeutics 2.68 Bn 2.68 Bn - -119.07 Mn
7 Precigen 2.44 Bn 2.44 Bn 52.17 Mn 20.07 Mn
8 Sarepta Therapeutics 2.35 Bn 1.55 Bn 251.87 Mn -4.89 Mn
9 Vericel 2.00 Bn 1.83 Bn 56.40 Mn 2.23 Mn
10 Mesoblast 246.02 Mn 143.11 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 -21.58 Mn
Mar 31, 2023 -18.69 Mn
Dec 31, 2022 -24.63 Mn
Sep 30, 2022 -16.99 Mn
Jun 30, 2022 162.09 Mn
Mar 31, 2022 -21.39 Mn
Dec 31, 2021 -26.11 Mn
Sep 30, 2021 -22.77 Mn
Jun 30, 2021 178.71 Mn
Mar 31, 2021 -26.71 Mn
Dec 31, 2020 -25.54 Mn
Sep 30, 2020 -26.00 Mn
Mar 31, 2020 -57.65 Mn
Dec 31, 2019 -38.47 Mn
Sep 30, 2019 -9.35 Mn
Jun 30, 2019 -27.08 Mn
Mar 31, 2019 -29.38 Mn
Dec 31, 2018 -30.33 Mn
Sep 30, 2018 -20.92 Mn
Jun 30, 2018 -22.88 Mn